Sodium 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate(CAS: 30123-17-2)

Sodium 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate (CAS: 30123-17-2) is a complex organic chemical compound containing a thiazepine ring and a heptanoate functional group. It is typically a white crystalline solid with moderate solubility in polar solvents. The compound is known for its structural features, which may make it relevant in pharmaceutical research and development.

Sodium 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate (CAS: 30123-17-2) is primarily used as a pharmaceutical intermediate in the synthesis of drugs targeting neurological disorders. Its chemical structure may also find applications in research for developing new therapeutic agents, and in industrial processes involving organic synthesis.

Sodium 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate (CAS: 30123-17-2) should be handled with standard chemical safety precautions. While specific toxicity data is limited, it is advisable to avoid direct skin contact, inhalation, and ingestion. Always refer to safety data sheets (SDS) for detailed handling and exposure guidelines.

Sodium 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate (CAS: 30123-17-2) should be stored in a sealed, airtight container in a cool, dry place away from direct light. Maintain storage conditions between 2-8°C to ensure stability, and avoid exposure to moisture or humidity to prevent degradation.